Maria Espinosa
Hematology & Oncology · Cleveland, OHNPI 1164411716
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.3% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 12.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $642 and has fallen 95.0% since, to $32 in 2024. That places this record below the midpoint for hematology & oncology clinicians in OH, where the typical reported total is $2,354.
Across 67 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$140
- AstraZeneca$129
- Astellas Pharma US Inc$80
- E.r. Squibb & Sons, L.L.C.$80
- Novartis$72
- Amgen$60
- plus $605 from 25 others
What the payments were for
- Food & beverage$1,08893%
- Education$787%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 1 | $140 |
| AstraZeneca(2 entities) | 9 | $129 |
| Astellas Pharma US Inc | 5 | $80 |
| E.r. Squibb & Sons, L.L.C. | 2 | $80 |
| Novartis | 5 | $72 |
| Amgen | 4 | $60 |
| Bristol Myers Squibb | 3 | $57 |
| Exelixis Inc. | 4 | $55 |
| AbbVie | 2 | $46 |
| Bayer | 3 | $46 |
| Merck | 3 | $39 |
| Eisai Inc. | 2 | $36 |
| GSK | 2 | $32 |
| Lilly USA, LLC | 2 | $29 |
| Sanofi | 2 | $24 |
| Shionogi Inc | 2 | $24 |
| Clovis Oncology, Inc. | 2 | $22 |
| Tesaro, Inc. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $17 |
| Actelion Pharmaceuticals US, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Genentech USA, Inc. | 1 | $13 |
| Epizyme, Inc. | 1 | $13 |
| Beigene USA, Inc. | 1 | $13 |
| Gilead | 1 | $12 |
| EMD Serono, Inc. | 1 | $11 |
| Octapharma USA, Inc. | 1 | $11 |
| Incyte Corporation | 1 | $11 |
| Rigel Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,166 in reported general payments places this provider in the 35th percentile of 450 hematology & oncology providers in Ohio.
Other hematology & oncology in Cleveland
- Hillard LazarusCleveland$2M
- Ronald BukowskiCleveland$594K
- Balazs HalmosCleveland$568K
- Jorge GarciaCleveland$513K
- Bachar DerghamCleveland$387K
- Brian HillCleveland$316K
- Dale ShepardCleveland$314K
- Sakti ChakrabartiCleveland$301K
- Keith McCraeCleveland$215K
- Megan KruseCleveland$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.